b
r
c
prrsv
caus
agent
import
infecti
diseas
affect
swine
herd
worldwid
produc
great
econom
loss
commerci
avail
vaccin
partial
effect
protect
prrsv
moreov
modifi
live
vaccin
may
allow
viru
shed
could
revert
gener
virul
phenotyp
therefor
new
effici
vaccin
requir
vaccin
base
recombin
viru
genom
viru
vector
vaccin
prrsv
could
repres
safe
altern
gener
modifi
live
vaccin
paper
current
vector
vaccin
protect
prrsv
revis
includ
base
pseudorabi
viru
poxviru
adenoviru
viru
replicon
special
attent
provid
use
transmiss
gastroenter
viru
tgev
vector
express
prrsv
antigen
vector
capabl
express
high
level
heterolog
gene
potent
induc
present
antigen
mucos
surfac
elicit
secretori
system
immun
tgev
deriv
vector
rtgev
gener
express
prrsv
wild
type
modifi
protein
describ
main
induc
neutral
antibodi
cellular
immun
respons
respect
protect
experi
show
vaccin
anim
develop
faster
stronger
humor
immun
respons
nonvaccin
one
partial
protect
challeng
anim
observ
vaccin
pig
show
decreas
lung
damag
compar
nonvaccin
one
nevertheless
level
neutral
antibodi
low
may
explain
limit
protect
observ
sever
strategi
propos
improv
current
rtgev
vector
express
prrsv
antigen
prrsv
caus
agent
import
infecti
diseas
affect
porcin
herd
worldwid
immun
respons
prrsv
poorli
understood
spite
vaccin
commerci
commerci
vaccin
mostli
modifi
live
vaccin
base
attenu
european
north
american
prrsv
strain
ie
ingelvac
prr
boehring
ingelheim
amervac
prr
hipra
syva
lab
nevertheless
inactiv
vaccin
also
avail
ie
progressi
merial
ingelvac
prr
kv
boehring
ingelheim
suipravac
prr
hipra
modifi
live
vaccin
preferenti
use
establish
protect
immun
measur
viral
load
blood
tissu
nevertheless
current
vaccin
prrsv
sever
limit
gener
modifi
live
vaccin
protect
challeng
homolog
isol
could
also
protect
heterolog
virus
diaz
et
al
zuckermann
et
al
furthermor
live
vaccin
provid
partial
protect
clinic
diseas
prevent
infect
osorio
et
al
importantli
revert
virul
botner
et
al
nielsen
et
al
attenu
vaccin
induc
immun
respons
resembl
induc
prrsv
natur
infect
induc
high
level
neutral
antibodi
kill
prrsv
vaccin
hand
gener
less
effect
prevent
infect
diseas
ostrowski
et
al
innat
immun
respons
prrsv
weak
probabl
contribut
delay
subsequ
humor
cellular
immun
respons
also
viru
persist
kimman
et
al
prrsv
induc
interferon
ifn
product
albina
et
al
calzadanova
et
al
key
element
host
antivir
respons
lead
minim
product
inflammatori
cytokin
activ
recruit
natur
killer
nk
cell
murtaugh
et
al
prrsvinduc
suppress
type
ifn
product
due
interfer
activ
promot
stimul
locat
downstream
sensor
molecul
rna
helicas
rigi
inactiv
avoid
ifn
regulatori
factor
irf
activ
consequ
type
ifn
product
luo
et
al
therefor
design
effect
vaccin
prrsv
would
advis
increas
product
type
ifn
date
differ
adjuv
promot
product
ifn
test
addit
current
vaccin
formul
limit
success
charerntantanakul
hallmark
swine
humor
respons
prrsv
product
nonneutr
antibodi
detect
earli
infect
follow
low
neutral
antibodi
nab
titer
detect
week
infect
kimman
et
al
murtaugh
et
al
one
possibl
explan
late
detect
nab
differ
techniqu
sensit
elisa
higher
sensit
neutral
assay
therefor
presenc
low
titer
nab
earli
infect
complet
discard
earli
nonneutr
antibodi
mainli
induc
nucleocapsid
n
protein
involv
antibodydepend
enhanc
prrsv
infect
mateu
diaz
murtaugh
et
al
nab
induc
protein
although
one
recogn
relev
protect
kim
yoon
ostrowski
et
al
two
b
cell
epitop
identifi
protein
ectodomain
immunodomin
epitop
ide
propos
act
decoy
epitop
epitop
critic
neutral
ecn
recogn
nab
ostrowski
et
al
sever
hypothesi
propos
explain
delay
nab
induct
protein
presenc
ide
glicanshield
ecn
lopez
osorio
role
nab
protect
demonstr
passiv
transfer
antibodi
protect
swine
prrsv
infect
correl
level
nab
propos
effici
vaccin
must
induc
nab
titer
prevent
prrsv
infect
lopez
et
al
prrsv
infect
result
weak
delay
cell
mediat
immun
respons
necessari
elimin
viru
mateu
diaz
murtaugh
et
al
shown
induct
secret
cell
complement
neutral
antibodi
provid
partial
protect
prrsv
zuckermann
et
al
interleukin
il
level
invers
correl
respons
propos
express
may
respons
suppress
cell
respons
charerntantanakul
et
al
kimman
et
al
protein
potent
induc
cell
prolifer
follow
bautista
et
al
may
play
role
protect
differ
vaccin
adjuv
test
improv
cell
respons
prrsv
nevertheless
addit
adjuv
includ
vaccin
formul
cpg
oligodeoxynucleotid
enhanc
protect
confer
current
vaccin
charerntantanakul
three
main
problem
develop
effici
vaccin
prrsv
correl
protect
well
known
prrsv
may
induc
neg
regulatori
signal
immun
system
extrem
larg
antigen
variabl
prrsv
structur
protein
indic
prrsv
heterodim
must
main
induc
protect
humor
cellular
respons
nevertheless
minor
structur
protein
also
requir
prrsv
virion
infect
wissink
et
al
may
play
role
protect
also
limit
inform
cell
epitop
implic
induct
protect
cell
respons
mateu
diaz
one
mechan
use
virus
suppress
evad
host
immun
respons
induct
regulatori
cell
treg
porcin
treg
phenotyp
kaser
et
al
describ
human
mice
belkaid
treg
classifi
natur
induc
latter
one
subdivid
three
subtyp
secret
helper
secret
transform
growth
factor
tgf
convert
treg
belkaid
recent
describ
american
type
prrsvinfect
dendrit
cell
induc
treg
effect
revert
addit
induc
treg
popul
type
promot
express
silvacampa
et
al
contrast
dendrit
cell
infect
eu
type
prrsv
virus
induc
treg
cell
although
exhibit
unbalanc
abil
stimul
cell
immun
respons
silvacampa
et
al
impact
treg
induct
delay
immun
respons
prrsv
infect
remain
establish
well
viral
protein
involv
process
prrsv
strain
extrem
divers
even
belong
genotyp
among
structur
protein
protein
conserv
one
variabl
one
dea
et
al
high
antigen
variabl
repres
problem
develop
univers
vaccin
prrsv
shown
low
efficaci
current
vaccin
heterolog
challeng
solv
problem
common
critic
b
cell
epitop
must
identifi
mateu
diaz
nevertheless
report
abil
vaccin
induc
strong
cellular
immun
respons
may
import
protect
genet
similar
challeng
strain
diaz
et
al
addit
problem
differ
immun
respons
elicit
prrsv
anim
differ
host
genet
background
lewi
et
al
therefor
knowledg
host
respons
prrsv
infect
requir
develop
effici
vaccin
mention
modifi
live
inactiv
vaccin
develop
prrsv
live
vaccin
led
better
result
killedviru
base
vaccin
nevertheless
live
attenu
vaccin
sever
problem
incomplet
protect
viru
shed
possibl
revers
virul
kimman
et
al
problem
increas
use
potenti
hazard
method
control
diseas
use
live
field
viru
vaccin
pig
vectorbas
vaccin
could
repres
advantag
stimul
humor
cell
immun
respons
prrsv
design
marker
vaccin
nevertheless
result
report
date
use
viral
vector
fulli
satisfactori
new
vector
antigen
combin
must
explor
prv
also
known
aujeszki
diseas
viru
adv
alphaherpesviru
classifi
within
famili
herpesvirida
prv
caus
agent
pseudorabi
worldwidespread
econom
import
diseas
swine
natur
host
prv
viru
also
infect
broad
rang
vertebr
includ
farm
anim
pomeranz
et
al
order
erad
viru
modifi
live
vaccin
success
use
vaccin
strain
ge
phenotyp
ie
ge
gene
delet
elimin
ge
caus
viru
attenu
reduc
viru
transmiss
reduc
viru
product
cell
cultur
induct
protect
immun
nauwynck
et
al
live
attenu
prv
use
vector
protect
swine
infecti
diseas
classic
swine
fever
hooft
van
iddeking
et
al
porcin
circoviru
ju
et
al
recombin
prv
base
attenu
bartha
strain
construct
express
prrsv
protein
qiu
et
al
protect
evalu
inocul
piglet
homolog
challeng
prrsv
strain
none
anim
even
inocul
commerci
avail
inactiv
vaccin
develop
antibodi
challeng
challeng
product
antibodi
detect
anim
nevertheless
none
produc
neutral
antibodi
prrsv
qiu
et
al
reduc
lung
lesion
viremia
faster
viru
elimin
tissu
observ
anim
inocul
prv
vaccin
vector
similar
found
anim
inocul
commerci
vaccin
qiu
et
al
altern
recombin
attenu
prv
vaccin
vector
express
differ
combin
prrsv
antigen
also
gener
vector
express
alon
togeth
protein
modifi
contain
pan
dr
thelper
cell
epitop
padr
decoy
epitop
ecn
recogn
nab
fang
et
al
alon
coexpress
protein
heterodim
detect
recombin
prv
coexpress
protein
suggest
prrsv
antigen
structur
chang
jiang
et
al
prv
coexpress
protein
promis
candid
induct
neutral
antibodi
lymphocyt
prolifer
test
mous
model
consequ
protect
confer
vector
evalu
porcin
respiratori
model
relat
protect
provid
commerci
avail
prrsv
kill
vaccin
anim
inocul
recombin
prv
express
prrsv
protein
develop
nab
challeng
furthermor
challeng
nab
titer
higher
anim
inocul
recombin
prrsv
compar
inocul
kill
vaccin
none
anim
inocul
empti
prv
develop
neutral
antibodi
time
experi
jiang
et
al
lymphocyt
prolif
respons
also
higher
anim
inocul
recombin
prv
express
protein
accordingli
lung
lesion
viremia
lower
anim
indic
certain
protect
homolog
challeng
jiang
et
al
adenovirus
current
one
extend
system
gene
deliveri
vector
high
capac
insert
foreign
gene
kb
kb
depend
system
abl
transduc
broad
rang
cell
type
bantouna
uney
differ
replicationdefect
recombin
adenovirus
rad
use
vector
prrsv
vaccin
develop
analysi
immunogen
properti
prrsv
wt
modifi
structur
protein
set
rad
express
prrsv
fusion
protein
gener
rad
test
mous
model
rad
express
fusion
protein
induc
increas
neutral
antibodi
humor
immun
respons
compar
mice
inocul
rad
express
protein
independ
empti
adenoviru
vector
rad
express
fusion
protein
also
induc
enhanc
lymphocyt
prolifer
cytotox
tlymphocyt
ctl
respons
unfortun
protect
confer
vector
evalu
porcin
system
author
also
gener
set
rad
express
prrsv
structur
protein
combin
alon
fusion
protein
mice
inocul
rad
express
fusion
protein
develop
higher
nab
titer
lymphocyt
prolifer
respons
inocul
rad
express
independ
prrsv
protein
interestingli
specif
ctl
respons
higher
mice
inocul
rad
express
fusion
protein
fact
author
select
recombin
rad
best
vaccin
candid
test
protect
pig
recombin
induc
nab
vaccin
piglet
challeng
higher
lymphocyt
prolifer
respons
product
nevertheless
rad
express
fusion
protein
fulli
protect
homolog
challeng
moder
decreas
lung
lesion
viremia
observ
wang
et
al
improv
efficaci
radbas
vaccin
heat
shock
protein
hsp
granulocytemacrophag
coloni
stimul
factor
gmcsf
coexpress
genet
adjuv
wang
et
al
set
rad
obtain
express
fusion
protein
five
glycin
proteas
linker
respect
piglet
inocul
rad
express
fusion
protein
induc
higher
nab
titer
produc
higher
level
present
reduc
lung
lesion
inocul
rad
express
protein
introduct
proteas
prrsv
fusion
protein
result
better
product
inocul
anim
also
lower
viremia
could
due
releas
nativ
higher
adjuv
activ
gmcsf
wide
use
effect
mucos
adjuv
toka
et
al
intranas
inocul
vector
express
gmcsf
stimul
product
lung
tissu
bukreyev
et
al
rad
express
fusion
protein
gener
moder
increas
nab
level
observ
challeng
piglet
inocul
rad
vector
compar
anim
inocul
empti
rad
rad
express
fusion
protein
alon
challeng
anim
inocul
rad
express
fusion
protein
contain
adjuv
develop
significantli
higher
nab
control
anim
lymphocyt
prolifer
respons
product
also
enhanc
anim
enhanc
immun
respons
correl
signific
decreas
viremia
lung
lesion
indic
gmcsf
enhanc
immunogen
radbas
vaccin
adenoviru
vector
also
use
evalu
antigen
prrsv
structur
protein
role
glycosyl
immun
respons
jiang
et
al
b
unfortun
studi
perform
use
mous
model
effect
protect
prrsv
recent
analyz
use
rad
piglet
inocul
rad
express
porcin
challeng
prrsv
brockmeier
et
al
result
obtain
indic
presenc
moder
protect
effect
prrsv
infect
poxvirus
largest
known
anim
dna
virus
extens
use
express
vector
vaccin
allow
express
larg
foreign
gene
induc
strong
cell
mediat
humor
immun
respons
safe
poxviru
vector
avail
paoletti
wang
et
al
fowlpox
first
poxviru
use
vaccin
vector
prrsv
guoshun
et
al
fowlpox
viru
fpv
belong
avipoxviru
genu
replic
restrict
avian
speci
nevertheless
attenu
strain
fpv
use
vector
poultri
mammal
result
strong
protect
immun
respons
paoletti
wang
et
al
fusion
protein
alon
combin
porcin
express
use
recombin
fpv
piglet
inocul
recombin
fpv
express
prrsv
antigen
induc
neutral
antibodi
dpi
higher
lymphocyt
prolifer
respons
inocul
empti
vector
guoshun
et
al
vaccin
anim
also
show
increas
product
compar
nonvaccin
one
piglet
vaccin
fpv
coexpress
prrsv
antigen
produc
higher
amount
inocul
fpv
express
fusion
protein
alon
guoshun
et
al
partial
protect
also
observ
challeng
homolog
strain
viremia
decreas
vaccin
anim
guoshun
et
al
modifi
vaccinia
viru
ankara
mva
member
orthopoxviru
genu
also
use
vector
prrsv
zheng
et
al
mva
use
vaccin
agent
prevent
smallpox
extens
use
viral
vector
infecti
diseas
cancer
mva
highli
attenu
even
immunosuppress
anim
induc
strong
humor
cellular
immun
respons
wang
et
al
four
recombin
mva
virus
express
prrsv
antigen
construct
express
protein
alon
fusion
protein
coexpress
protein
zheng
et
al
vector
test
mous
model
mice
inocul
recombin
mva
express
heterolog
antigen
develop
prrsv
neutral
antibodi
highest
antibodi
titer
found
mice
inocul
recombin
mva
coexpress
protein
similar
result
obtain
product
analyz
indic
type
cellular
immun
respons
zheng
et
al
unfortun
author
perform
protect
experi
piglet
therefor
use
mva
vector
prrsv
vaccin
remain
determin
express
vector
engin
use
differ
viral
replicon
replac
viru
structur
gene
heterolog
one
rna
vector
replicon
express
high
level
foreign
protein
replic
packag
viruslik
particl
unless
structur
protein
provid
tran
therefor
replicon
spread
neighbor
cell
safe
use
vaccin
nagai
et
al
rayner
et
al
alphaviru
replicon
deriv
venezuelan
equin
enceph
viru
veev
success
use
vaccin
differ
pathogen
includ
swine
influenza
veevderiv
vaccin
induc
robust
humor
mucos
cellular
immun
rayner
et
al
recent
describ
veev
replicon
express
prrsv
protein
reduc
viremia
prrsv
challeng
provid
partial
protect
mogler
et
al
replicon
classic
swine
fever
viru
csfv
vesicular
stomat
viru
vsv
express
protein
also
gener
express
high
level
prrsv
antigen
n
ruggli
person
commun
coronavirus
sever
advantag
vector
viral
express
system
singlestrand
rna
virus
replic
cytoplasm
without
dna
intermediari
make
integr
viru
genom
host
cell
chromosom
unlik
lai
cavanagh
ii
virus
largest
rna
viru
genom
principl
room
insert
larg
foreign
gene
enjuan
et
al
enjuan
et
al
iii
pleiotrop
secretori
immun
respons
best
induc
stimul
gut
associ
lymphoid
tissu
sinc
coronavirus
gener
infect
respiratori
enter
mucos
surfac
virus
may
use
target
antigen
enter
respiratori
area
induc
strong
secretori
immun
respons
iv
tropism
coronavirus
may
engin
modifi
gene
ballestero
et
al
kuo
et
al
sanchez
et
al
v
nonpathogen
coronaviru
strain
infect
speci
interest
human
porcin
bovin
canin
felin
avian
avail
therefor
suitabl
develop
safe
viru
vector
vi
infecti
coronaviru
cdna
clone
avail
design
express
system
group
obtain
first
infecti
coronaviru
cdna
clone
tgev
cdna
propag
bacteri
artifici
chromosom
bac
et
al
gonzalez
et
al
vector
base
infecti
cdna
engin
clone
foreign
gene
place
previous
occupi
nonessenti
gene
lead
high
cell
stabl
passag
express
level
specif
heterolog
gene
enjuan
et
al
ortego
et
al
sola
et
al
foreign
gene
express
level
optim
studi
transcriptionregul
sequenc
trss
involv
coronaviru
gene
express
group
gener
set
trss
rang
intermedi
high
foreign
gene
express
level
alonso
et
al
combin
trss
could
use
drive
express
two
three
heterolog
gene
one
infecti
cdna
ie
dicistron
tricistron
vector
tgev
deriv
vector
biosafeti
improv
gener
replicationcompet
propagationdefici
virus
ortego
et
al
porcin
respiratori
coronaviru
prcv
mutant
tgev
replic
respiratori
tract
caus
mild
clinic
sign
prcv
spread
worldwid
induc
antibodi
also
neutral
tgev
saif
et
al
therefor
preexist
immun
tgev
vector
could
problem
nevertheless
vivo
experi
show
antibodi
titer
tgev
increas
even
two
reinfect
pig
rtgev
vector
alonso
sola
enjuan
l
unpublish
result
one
main
advantag
recombin
tgev
rtgev
vector
prrsv
tgev
potent
induc
process
mediat
viru
transmembran
protein
calzadanova
et
al
charley
laud
addit
mention
tgev
vector
may
present
antigen
mucos
site
elicit
mucos
system
immun
respons
therefor
rtgev
vector
repres
novel
strategi
studi
induct
protect
prrsv
prrsv
structur
protein
accumul
endoplasm
reticulum
infect
cell
form
disulfidelink
heterodim
incorpor
virion
protein
fig
predict
heterodim
topolog
prrsv
heterodim
may
anchor
membran
protein
expos
surfac
short
ntermin
ectodomain
protein
ectodomain
contain
protein
motiv
relev
antigen
epitop
critic
neutral
ecn
purpl
decoy
immunodomin
epitop
ide
green
signal
peptid
red
cleavag
repres
black
arrowhead
protein
contain
predict
glycosyl
site
yellow
although
protein
glycosyl
repres
orang
circl
protein
contain
ctermin
endoplasm
reticulum
retent
signal
dark
green
homodim
also
detect
infect
cell
incorpor
viru
particl
dea
et
al
meulenberg
protein
essenti
product
viral
particl
although
addit
minor
envelop
protein
requir
virion
infect
wissink
et
al
accord
accept
topolog
heterodim
fig
protein
expos
short
ectodomain
virion
surfac
involv
receptor
recognit
ectodomain
contain
sever
glycosyl
site
depend
viral
strain
describ
protein
heterodim
format
previou
glycosyl
mardassi
et
al
glycosyl
site
close
ecn
epitop
propos
steric
hindranc
caus
glycosyl
one
caus
potenti
delay
product
nab
prrsv
infect
see
recent
describ
heterodim
interact
prrsv
receptor
porcin
fig
design
rtgev
express
prrsv
antigen
scheme
tgev
infecti
cdna
clone
clone
bac
pbactgev
fl
transfect
cell
fulllength
viru
genom
gener
rtgev
cmv
cytomegaloviru
immediateearli
promot
polya
tail
residu
hdv
hepat
delta
viru
ribozym
bgh
bovin
growth
hormon
termin
polyadenyl
sequenc
tgev
deriv
vector
base
tgev
genom
nonessenti
gene
delet
gene
encod
prrsv
heterolog
protein
clone
posit
express
foreign
gene
driven
transcript
regulatori
sequenc
trss
gene
n
addit
mutant
lack
glycosyl
site
decoy
epitop
obtain
case
rtgev
virus
recov
high
titer
b
st
cell
infect
rtgev
doubl
immunofluoresc
stain
perform
tgev
n
protein
specif
monoclon
antibodi
secondari
antibodi
stain
red
use
identifi
virusinfect
cell
express
detect
rabbit
antiserum
specif
peptid
coupl
secondari
antibodi
stain
green
upper
panel
express
protein
detect
rabbit
antiserum
specif
protein
peptid
coupl
secondari
antibodi
stain
green
lower
panel
percentag
infect
cell
express
prrsv
antigen
estim
analysi
differ
microscop
field
sialoadhesin
interact
depend
glycosyl
like
glycosyl
site
overlap
epitop
recogn
neutral
antibodi
van
breedam
et
al
describ
protein
involv
induct
prrsv
neutral
antibodi
strong
cellular
immun
respons
respect
bautista
et
al
ostrowski
et
al
data
indic
heterodim
promis
antigen
structur
could
use
construct
efficaci
vaccin
prrsv
dicistron
tgev
cdna
encod
prrsv
protein
engin
fig
prrsv
gene
clone
place
nonessenti
gene
express
driven
transcriptionregul
sequenc
gene
protein
express
optim
tr
partial
deriv
gene
n
alonso
et
al
therefor
prrsv
gene
express
independ
subgenom
mrna
recov
viru
express
protein
studi
protein
express
rtgev
also
coloc
confoc
microscopi
analysi
perform
st
cell
infect
prrsv
rtgev
respect
doubl
immunofluoresc
stain
perform
express
detect
monoclon
antibodi
specif
coupl
secondari
antibodi
stain
red
upper
panel
express
protein
detect
rabbit
antiserum
specif
protein
peptid
coupl
secondari
antibodi
stain
green
medium
panel
shown
merg
coloc
protein
observ
prrsv
rtgev
infect
cell
lower
panel
mutant
protein
express
rtgev
also
coloc
protein
rtgev
infect
cell
respect
fig
b
express
level
maintain
even
viru
recov
tissu
infect
piglet
rtgev
result
substanti
advanc
efficaci
previou
rtgev
express
individu
prrsv
antigen
show
high
express
level
limit
stabil
coexpress
protein
reduc
toxic
probabl
elicit
better
cell
immun
respons
protect
confer
vector
test
vivo
oneweekold
piglet
inocul
pfu
rtgev
three
rout
oral
nasal
intragastr
nine
week
later
challeng
perfom
tcid
virul
european
prrsv
strain
blood
sampl
collect
differ
time
postinocul
humor
immun
respons
evalu
elisa
anim
present
high
antibodi
respons
tgev
therefor
vector
infect
target
tissu
expect
vaccin
anim
also
show
clear
humor
respons
prrsv
protein
fast
recal
immun
respons
observ
challeng
vaccin
anim
induc
higher
antibodi
titer
prrsv
antigen
earlier
control
one
nevertheless
immun
respons
elicit
rtgev
provid
limit
protect
antibodi
titer
decreas
challeng
lack
protect
challeng
like
due
rel
low
level
neutral
antibodi
produc
challeng
nevertheless
result
use
rtgev
platform
promis
humor
immun
respons
prrsv
antigen
elicit
antigen
may
problem
obtent
effici
vaccin
therefor
sever
strategi
chang
antigen
structur
perform
fig
case
mutant
coexpress
protein
use
dicistron
vector
minim
toxic
problem
due
product
ectodomain
protein
nglycosyl
three
four
predict
glycosyl
site
north
american
strain
prrsv
wherea
two
site
protein
european
strain
wt
fig
relev
nglycan
antigen
clear
propos
remov
glycosyl
site
could
lead
improv
immun
respons
prrsv
due
elimin
steric
hindranc
rais
carbohydr
epitop
induc
nab
ansari
et
al
elimin
glycosyl
site
present
north
american
strain
engin
natur
prrsv
mutant
led
increas
level
nab
induc
mutant
virus
ansari
et
al
faaberg
et
al
nevertheless
worth
note
site
present
european
prrsv
strain
although
elimin
glycosyl
site
overlap
epitop
critic
neutral
fig
often
lead
noninfecti
virus
ansari
et
al
wissink
et
al
natur
north
american
strain
mutant
lack
glycosyl
site
found
sequenc
protein
surprisingli
one
natur
mutant
elicit
lower
neutral
antibodi
respons
wildtyp
prrsv
strain
faaberg
et
al
contrast
data
obtain
lactat
dehydrogenaseelev
viru
ldv
delet
nglycan
enhanc
nab
respons
plagemann
moenngin
elimin
conserv
nglycosyl
site
fig
sequenc
north
american
protein
lack
motif
led
higher
level
neutral
antibodi
compar
respons
elicit
wildtyp
viru
ansari
glycosyl
probabl
also
involv
viru
infect
difficult
analyz
influenc
nglycan
immunogen
protein
rtgev
system
prrsv
involv
infect
therefor
relev
protein
antigen
protect
could
analyz
laboratori
use
rtgev
vector
mutant
lack
glycosyl
site
gener
fig
mutat
asn
ser
select
case
substitut
like
introduc
littl
secondari
structur
modif
also
prrsv
field
strain
bear
similar
asn
ser
aminoacid
mutat
put
glycosyl
site
rtgev
virus
recov
high
titer
fig
nevertheless
mutant
lack
glycosyl
site
partial
overlap
ecn
stabl
fig
b
rtgev
vector
express
high
level
prrsv
protein
infect
cell
respect
fig
b
sever
b
cell
epitop
found
protein
immunodomin
epitop
locat
endodomain
therefor
probabl
limit
effect
antigen
ecn
epitop
expos
viral
surfac
dea
et
al
oleksiewicz
et
al
rodriguez
et
al
second
immunodomin
epitop
ide
describ
ectodomain
close
ecn
fig
ostrowski
et
al
suggest
immunodomin
site
could
respons
delay
product
nab
prrsv
act
decoy
epitop
antibodi
ide
ecn
epitop
found
sera
prrsv
infect
pig
appear
differ
time
postinfect
furthermor
increas
titer
ecn
correl
decreas
level
antibodi
specif
ide
lopez
osorio
ostrowski
et
al
enhanc
immunogen
recombin
protein
synthet
sequenc
spacer
introduc
ide
ecn
epitop
better
display
neutral
epitop
report
data
suggest
ide
fact
act
decoy
epitop
fang
et
al
rtgev
vector
engin
express
mutant
lack
ide
order
clarifi
whether
epitop
act
decoy
epitop
enhanc
product
prrsv
specif
nab
approach
repres
advanc
similar
construct
made
prrsv
infecti
cdna
clone
case
delet
decoy
epitop
prevent
recoveri
recombin
viru
ansari
et
al
two
modif
combin
within
construct
express
protein
lack
decoy
epitop
glycosyl
site
overlap
epitop
recogn
neutral
antibodi
fig
rtgev
viru
recov
high
titer
fig
express
modifi
protein
infect
cell
respect
fig
b
data
obtain
cultur
cell
suggest
rtgev
vector
express
prrsv
antigen
fulli
stabl
mainli
due
protein
toxic
result
signific
lost
express
viru
vector
passag
cell
cultur
contrast
protein
express
fulli
stabl
least
infect
cell
express
protein
passag
tissu
cultur
decreas
express
also
observ
introduct
modif
protein
upper
panel
fig
b
protein
express
remain
constant
independ
mutant
coexpress
lower
panel
fig
b
reduct
express
could
respons
modest
result
protect
observ
live
rtgev
vector
comparison
protect
elicit
noninfecti
antigen
express
use
rtgev
vector
describ
rtgev
vector
express
prrsv
protein
repres
substanti
advanc
efficaci
previou
rtgev
express
prrsv
antigen
ie
alon
postul
coexpress
protein
reduc
toxic
format
heterodim
clarifi
issu
confoc
microscopi
analysi
perform
fig
st
cell
infect
prrsv
rtgev
respect
doubl
immunofluoresc
stain
perform
shown
merg
fig
lower
panel
coloc
protein
observ
prrsv
rtgev
infect
cell
result
suggest
heterodim
form
case
decreas
express
level
introduct
mutat
suggest
modif
could
affect
heterodim
format
coloc
protein
also
observ
mutant
protein
ie
express
rtgev
vector
fig
suggest
heterodim
also
form
mutant
protein
coimmunoprecipit
protein
fulli
demonstr
heterodim
format
progress
protect
confer
rtgev
deriv
vaccin
formul
kill
vaccin
express
mutant
alter
glycosyl
pattern
complementari
approach
kill
vaccin
develop
base
viru
coexpress
lack
first
glycosyl
site
protein
st
cell
infect
rtgev
cultur
medium
harvest
hpi
solubl
antigen
inactiv
incub
binari
ethylenimin
bei
vaccin
formul
group
six
piglet
intramuscularli
inocul
formul
evalu
protect
confer
vaccin
boost
perform
week
inocul
six
week
first
inocul
anim
challeng
intranas
inocul
tcid
strain
blood
sampl
collect
differ
time
postinocul
determin
level
specif
antibodi
elisa
vaccin
anim
induc
higher
faster
antibodi
titer
prrsv
antigen
control
anim
fig
left
panel
neutral
antibodi
titer
also
higher
vaccin
anim
compar
nonvaccin
anim
fig
right
panel
viremia
gross
lesion
histopatholog
lung
vaccin
nonvaccin
anim
analyz
clear
degre
protect
sampl
analyz
enzymelink
immunosorb
assay
elisa
specif
detect
antibodi
tgev
evalu
respons
protein
prrsv
strain
express
purifi
insect
cell
use
antigen
elisa
b
lung
damag
caus
prrsv
infect
lung
anim
inocul
empti
rtgev
vector
rtgev
express
protein
analyz
lung
lesion
observ
pig
differ
degre
sever
includ
craneoventr
consolid
apic
medial
lung
lobe
observ
lung
vaccin
anim
show
significantli
lower
degre
lung
damag
nonvaccin
one
fig
b
left
panel
furthermor
reduct
viremia
also
observ
vaccin
anim
fig
b
right
panel
altogeth
data
suggest
elimin
glycosyl
site
close
neutral
epitop
improv
protect
immun
respons
prrsv
protect
confer
test
vivo
oneweekold
piglet
inocul
pfu
rtgev
three
rout
oral
nasal
intragastr
boost
perform
week
inocul
six
week
later
challeng
perform
tcid
strain
blood
sampl
collect
differ
time
postinocul
humor
immun
respons
evalu
elisa
anim
produc
high
antibodi
respons
tgev
data
shown
therefor
vector
infect
target
tissu
expect
challeng
vaccin
anim
show
clear
humor
respons
prrsv
antigen
fig
moder
faster
recal
respons
observ
vaccin
anim
induc
higher
antibodi
titer
prrsv
antigen
earlier
control
anim
fig
protect
confer
tgev
base
vaccin
also
evalu
certain
degre
protect
observ
lung
vaccin
anim
show
lower
degre
lung
damag
nonvaccin
one
fig
b
nevertheless
immun
respons
strong
enough
provid
full
protect
probabl
level
neutral
antibodi
similar
vaccin
nonvaccin
anim
data
shown
date
rtgev
express
prrsv
antigen
provid
partial
protect
could
due
fact
express
prrsv
antigen
rtgev
vector
fulli
stabl
mainli
due
protein
toxic
result
signific
lost
express
passag
contrast
protein
express
fulli
stabl
least
infect
cell
express
protein
passag
tissu
cultur
lack
full
protect
use
rtgev
express
prrsv
antigen
could
also
due
presenc
domain
express
protein
induc
neg
regulatori
cell
treg
vector
use
immun
rtgev
effici
induc
product
ifn
like
either
prrsv
protein
could
contain
neg
signal
induc
treg
neg
regul
immun
respons
elicit
could
also
major
caus
delay
develop
protect
immun
respons
prrsv
improv
rtgev
vector
stabil
differ
strategi
develop
express
small
domain
contain
epitop
relev
protect
lack
domain
respons
instabl
express
altern
gener
librari
point
mutant
fragment
epitop
elicit
neg
treg
elimin
may
overcom
consid
second
relev
limit
protect
prrsv
approach
current
progress
laboratori
improv
vaccin
strategi
prrsv
requir
current
vaccin
limit
efficaci
best
result
obtain
use
modifi
live
vaccin
viru
vector
vaccin
could
repres
advantag
stimul
immun
respons
prrsv
result
report
date
use
viral
vector
fulli
satisfactori
new
vector
must
explor
tgev
base
vector
vaccin
express
differ
prrsv
antigen
combin
repres
promis
candid
provid
protect
two
porcin
virus
prrsv
tgev
use
rtgev
vector
led
promis
result
similar
obtain
vector
vaccin
nevertheless
report
rna
virus
data
obtain
indic
heterolog
protein
express
stabil
limit
therefor
increas
prrsv
antigen
express
stabil
remov
domain
elicit
treg
repres
new
avenu
improv
develop
effici
prrsv
vaccin
